Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

Robert K. Hills(Cardiff University), Sylvie Castaigné(Centre Hospitalier de Versailles), Frederick R. Appelbaum(Fred Hutch Cancer Center), Jacques Delaunay(Clinique Jules Verne), Stephen H. Petersdorf(Fred Hutch Cancer Center), Megan Othus(Fred Hutch Cancer Center), Elihu H. Estey(Fred Hutch Cancer Center), Hervé Dombret(Université Paris Cité), Sylvie Chevret(Centre Hospitalier de Versailles), Norbert Ifrah(Centre National de la Recherche Scientifique), Jean‐Yves Cahn(Université Grenoble Alpes), Christian Récher(Centre Hospitalier Universitaire de Toulouse), Lucy Chilton(Newcastle University), Anthony V. Moorman(Newcastle University), Alan K. Burnett(Cardiff University)
The Lancet Oncology
July 6, 2014
Cited by 689Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis